Answers are grounded in this paper and cite their sources.
Immune checkpoint inhibitors represent a major advance in the treatment of cancer. The authors argue that future efforts should focus less on redundant agents and more on new approaches to immunotherapy.
No takes yet. Share an insight, caveat, or question.
Johnson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: